Craig W Hendrix

23PUBLICATIONS

82CO-AUTHORS

Nanotoxicology, health and safetyPreventative health careInnate immunityTechnology, crime and surveillanceObstetrics and gynaecology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|May 20, 2026

Author Correction: Pharmacological markers of HIV prevention for oral pre-exposure prophylaxis in men who have sex with men.

|May 09, 2026

Pharmacological markers of HIV prevention for oral pre-exposure prophylaxis in men who have sex with men.

|Mar 23, 2026

Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.

Sean M Hughes, Fernanda L Calienes, Claire N Levy

|Nov 08, 2025

Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083.

Brett Hanscom, Mark A Marzinke, Xinnong Li

|Oct 31, 2025

Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084.

Mark A Marzinke, Brett Hanscom, Daniel Haines

|Jun 27, 2025

Safety, Pharmacokinetics, and Acceptability of a Tenofovir Rectal Microbicide Douche Among Young Men Who Have Sex With Men: The DREAM ATN Study (ATN 163).

Jose A Bauermeister, Renata Arrington-Sanders, Jessica Coleman-Lewis

Pageof 4

Frequent Collaborators

Mark A Marzinke

Mina C Hosseinipour

Raphael J Landovitz

Max von Kleist

Richard B Pyles

Sandra Massih

Ruohui Zheng

Beatriz Grinsztejn

Peter L Anderson

Peter A Anton

Frequent Collaborators

Mark A Marzinke

Mina C Hosseinipour

Raphael J Landovitz

Max von Kleist